Valuation: RaySearch Laboratories AB

Market Cap 719.25Cr 74Cr 65Cr 60Cr 56Cr 105.05Cr 6.98TCr 107.24Cr 278.31Cr 3.45TCr 278.03Cr 271.96Cr 12TCr P/E 2026 *
25.2x
P/E 2027 * 20.2x
Enterprise Value 710.25Cr 73Cr 64Cr 59Cr 55Cr 103.74Cr 6.9TCr 105.89Cr 274.83Cr 3.41TCr 274.55Cr 268.55Cr 12TCr EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.32x
Free-Float
80.09%
Yield 2026 *
1.91%
Yield 2027 * 2.47%
1 day+1.11%
1 week+1.35%
Current month-4.17%
1 month-4.73%
3 months+14.38%
6 months-7.14%
Current year-8.36%
1 week 201.1
Extreme 201.1
216.4
1 month 201.1
Extreme 201.1
227.6
Current year 167.6
Extreme 167.6
237
1 year 167.6
Extreme 167.6
369.5
3 years 56.5
Extreme 56.5
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.11%+1.35% - - 74Cr
+8.40%+11.78%-39.54%-15.04% 2.78TCr
+1.88%+9.31%-32.68%+189.21% 1.36TCr
-1.01%-1.08%-20.41%+57.72% 543.05Cr
+1.92%+5.98% - - 307.45Cr
+0.30%+13.66% - - 211.13Cr
+1.52%+2.77%+36.59%-41.96% 182.51Cr
-1.43%-7.17%-31.18% - 121.77Cr
-1.55%+29.80%+606.67%+863.64% 73Cr
-3.38%-9.25%-44.82%-62.97% 72Cr
Average +0.78%+6.09%+67.80%+165.10% 628.45Cr
Weighted average by Cap. +4.52%+8.93%-23.74%+59.37%

Financials

2026 *2027 *
Net sales 140.9Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.37TCr 21Cr 55Cr 676.23Cr 54Cr 53Cr 2.34TCr 160.3Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.56TCr 24Cr 62Cr 769.34Cr 62Cr 61Cr 2.67TCr
Net income 28Cr 2.93Cr 2.57Cr 2.37Cr 2.22Cr 4.16Cr 276.76Cr 4.25Cr 11Cr 136.78Cr 11Cr 11Cr 474.3Cr 36Cr 3.65Cr 3.2Cr 2.95Cr 2.77Cr 5.19Cr 344.74Cr 5.29Cr 14Cr 170.38Cr 14Cr 13Cr 590.79Cr
Net Debt -9Cr -92.65L -81.23L -74.88L -70.1L -1.31Cr -87Cr -1.34Cr -3.48Cr -43Cr -3.48Cr -3.4Cr -149.78Cr -26Cr -2.73Cr -2.39Cr -2.2Cr -2.06Cr -3.87Cr -257.34Cr -3.95Cr -10Cr -127.18Cr -10Cr -10Cr -441.01Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
26/26/26 SEK 211.00 +2.91% 15,017
25/26/25 SEK 205.04 +0.80% 365
24/26/24 SEK 203.40 -2.87% 3,188
23/26/23 SEK 209.41 +0.22% 11,825
22/26/22 SEK 208.95 +1.14% 616
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
209.80SEK
Average target price
330.00SEK
Spread / Average Target
+57.29%

Quarterly revenue - Rate of surprise